Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nordea and Swedbank in connection with K2A’s establishment of its MTN programme
Mandate

Vinge advises Nordea and Swedbank in connection with K2A’s establishment of its MTN programme

May 21, 2021 Banking and Finance

Vinge has advised Nordea Bank Abp and Swedbank AB (publ) as lead arrangers and issuing agents in connection with the structuring, documenting and establishment of K2A Knaust & Andersson Fastigheter AB (publ) (”K2A”) unsecured medium term note programme (the “MTN Programme”). The MTN Programme is part of K2A’s debt financing and allows K2A to issue senior unsecured medium term notes in an aggregate amount of up to SEK 3,000,000,000 in SEK or EUR, with a minimum tenor of one year.

In contrast to customary MTN programmes, the MTN Programme was structured to be aligned with the terms and structure of high yield bonds issued on a standalone basis – making the MTN Programme one of the first of its kind in Sweden.

K2A has prepared a base prospectus which has been approved by, and registered with, the Swedish Financial Supervisory Authority.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Felix Möller.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026